Published in Eur Heart J on December 13, 2012
Effectiveness of remote monitoring of CIEDs in detection and treatment of clinical and device-related cardiovascular events in daily practice: the HomeGuide Registry. Europace (2013) 2.65
EuroEco (European Health Economic Trial on Home Monitoring in ICD Patients): a provider perspective in five European countries on costs and net financial impact of follow-up with or without remote monitoring. Eur Heart J (2014) 1.51
Patient perspective on remote monitoring of cardiovascular implantable electronic devices: rationale and design of the REMOTE-CIED study. Neth Heart J (2014) 0.92
Costs of remote monitoring vs. ambulatory follow-ups of implanted cardioverter defibrillators in the randomized ECOST study. Europace (2014) 0.92
2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing. J Arrhythm (2016) 0.88
Economic impact of remote monitoring on ordinary follow-up of implantable cardioverter defibrillators as compared with conventional in-hospital visits. A single-center prospective and randomized study. J Interv Card Electrophysiol (2013) 0.82
Cost-consequence analysis of daily continuous remote monitoring of implantable cardiac defibrillator and resynchronization devices in the UK. Europace (2013) 0.80
Remote monitoring of patients with cardiac implantable electronic devices: a Southeast Asian, single-centre pilot study. Singapore Med J (2016) 0.78
Clinical experience with subcutaneous implantable cardioverter-defibrillators. Nat Rev Cardiol (2015) 0.78
Remote monitoring of patients with Implantable Cardioverter Defibrillators (ICD): a cute gimmick or an essential tool for clinical excellence? J Cardiovasc Electrophysiol (2014) 0.76
Cardiac Pacing - Is Telemonitoring Now Essential? Arrhythm Electrophysiol Rev (2013) 0.75
Remote monitoring of cardiac implantable electronic devices (CIED). Trends Cardiovasc Med (2016) 0.75
Remote Monitoring for Follow-up of Patients with Cardiac Implantable Electronic Devices. Arrhythm Electrophysiol Rev (2014) 0.75
Low rate of and rapid attention to inappropriate ICD shocks with remote device and rhythm monitoring: a qualitative study. Open Heart (2015) 0.75
Battery drain in daily practice and medium-term projections on longevity of cardioverter-defibrillators: an analysis from a remote monitoring database. Europace (2016) 0.75
Improved survival in patients enrolled promptly into remote monitoring following cardiac implantable electronic device implantation. J Interv Card Electrophysiol (2016) 0.75
The Significance of Shocks in Implantable Cardioverter Defibrillator Recipients. Arrhythm Electrophysiol Rev (2016) 0.75
[Implantable cardioverter-defibrillator: Is remote monitoring obligatory?]. Herzschrittmacherther Elektrophysiol (2015) 0.75
[Inappropriate ICD therapies: All problems solved with MADIT-RIT?]. Herzschrittmacherther Elektrophysiol (2015) 0.75
Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact. J Am Coll Cardiol (2008) 4.63
Efficacy and safety of automatic remote monitoring for implantable cardioverter-defibrillator follow-up: the Lumos-T Safely Reduces Routine Office Device Follow-up (TRUST) trial. Circulation (2010) 4.07
Complication rates associated with pacemaker or implantable cardioverter-defibrillator generator replacements and upgrade procedures: results from the REPLACE registry. Circulation (2010) 2.93
The CONNECT (Clinical Evaluation of Remote Notification to Reduce Time to Clinical Decision) trial: the value of wireless remote monitoring with automatic clinician alerts. J Am Coll Cardiol (2011) 2.51
Long-term outcome after ICD and CRT implantation and influence of remote device follow-up: the ALTITUDE survival study. Circulation (2010) 2.45
Risk factors related to infections of implanted pacemakers and cardioverter-defibrillators: results of a large prospective study. Circulation (2007) 2.36
Inappropriate implantable cardioverter-defibrillator shocks: incidence, predictors, and impact on mortality. J Am Coll Cardiol (2011) 2.31
Potential role of home monitoring to reduce inappropriate shocks in implantable cardioverter-defibrillator patients due to lead failure. Europace (2008) 2.19
Quality of life in the antiarrhythmics versus implantable defibrillators trial: impact of therapy and influence of adverse symptoms and defibrillator shocks. Circulation (2002) 2.16
Remote, wireless, ambulatory monitoring of implantable pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy systems: analysis of a worldwide database. Pacing Clin Electrophysiol (2007) 1.88
Home monitoring remote control of pacemaker and implantable cardioverter defibrillator patients in clinical practice: impact on medical management and health-care resource utilization. Europace (2008) 1.85
What evidence do we have to replace in-hospital implantable cardioverter defibrillator follow-up? Clin Res Cardiol (2006) 1.65
Complications of implantable cardioverter defibrillator therapy in 440 consecutive patients. Pacing Clin Electrophysiol (2005) 1.64
Potential role of remote monitoring for scheduled and unscheduled evaluations of patients with an implantable defibrillator. Europace (2008) 1.44
Contributions of remote monitoring to the follow-up of implantable cardioverter-defibrillator leads under advisory. Eur Heart J (2010) 1.21
Automatic home monitoring of implantable cardioverter defibrillators. Europace (2008) 1.21
Remote implantable cardioverter defibrillator monitoring in a Brugada syndrome population. Europace (2009) 0.93
Work burden with remote monitoring of implantable cardioverter defibrillator: is it time for reimbursement policies? J Cardiovasc Med (Hagerstown) (2013) 0.83
Electronic cardiac medicine: present and future opportunities. Swiss Med Wkly (2010) 0.82
Sudden cardiac arrest associated with early repolarization. N Engl J Med (2008) 8.26
Catheter ablation for atrial fibrillation in congestive heart failure. N Engl J Med (2004) 4.99
Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: the A4 study. Circulation (2008) 4.43
Mapping and ablation of idiopathic ventricular fibrillation. Circulation (2002) 3.69
Catheter ablation of long-lasting persistent atrial fibrillation: critical structures for termination. J Cardiovasc Electrophysiol (2005) 3.58
Catheter ablation of long-lasting persistent atrial fibrillation: clinical outcome and mechanisms of subsequent arrhythmias. J Cardiovasc Electrophysiol (2005) 3.46
Technique and results of linear ablation at the mitral isthmus. Circulation (2004) 2.74
Changes in atrial fibrillation cycle length and inducibility during catheter ablation and their relation to outcome. Circulation (2004) 2.63
Mapping and ablation of ventricular fibrillation associated with long-QT and Brugada syndromes. Circulation (2003) 2.56
Characterization of electrograms associated with termination of chronic atrial fibrillation by catheter ablation. J Am Coll Cardiol (2008) 2.50
Irrigated-tip catheter ablation of pulmonary veins for treatment of atrial fibrillation. J Cardiovasc Electrophysiol (2002) 2.36
Risk factors related to infections of implanted pacemakers and cardioverter-defibrillators: results of a large prospective study. Circulation (2007) 2.36
Characteristics of recurrent ventricular fibrillation associated with inferolateral early repolarization role of drug therapy. J Am Coll Cardiol (2009) 2.21
Classifying fractionated electrograms in human atrial fibrillation using monophasic action potentials and activation mapping: evidence for localized drivers, rate acceleration, and nonlocal signal etiologies. Heart Rhythm (2010) 2.19
Incidence and prognosis of sustained arrhythmias in critically ill patients. Am J Respir Crit Care Med (2008) 2.17
Catheter ablation of recurrent scar-related ventricular tachycardia using electroanatomical mapping and irrigated ablation technology: results of the prospective multicenter Euro-VT-study. J Cardiovasc Electrophysiol (2009) 2.14
Prevalence of pulmonary vein disconnection after anatomical ablation for atrial fibrillation: consequences of wide atrial encircling of the pulmonary veins. Eur Heart J (2005) 2.14
Impact of the control of symptomatic paroxysmal atrial fibrillation on health-related quality of life. Europace (2010) 2.12
High-density activation mapping of fractionated electrograms in the atria of patients with paroxysmal atrial fibrillation. Heart Rhythm (2006) 2.10
Indications for the use of diagnostic implantable and external ECG loop recorders. Europace (2009) 2.06
Long-term follow-up of asymptomatic Brugada patients with inducible ventricular fibrillation under hydroquinidine. Europace (2013) 2.02
Electroanatomic characterization of post-infarct scars comparison with 3-dimensional myocardial scar reconstruction based on magnetic resonance imaging. J Am Coll Cardiol (2008) 2.00
Left atrial linear lesions are required for successful treatment of persistent atrial fibrillation. Eur Heart J (2008) 1.98
Mechanisms of right atrial tachycardia occurring late after surgical closure of atrial septal defects. J Cardiovasc Electrophysiol (2005) 1.98
Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on Atrial Fibrillation. Eur Heart J (2006) 1.84
A randomized comparison of triple-site versus dual-site ventricular stimulation in patients with congestive heart failure. J Am Coll Cardiol (2008) 1.81
Techniques, evaluation, and consequences of linear block at the left atrial roof in paroxysmal atrial fibrillation: a prospective randomized study. Circulation (2005) 1.75
Role of Purkinje conducting system in triggering of idiopathic ventricular fibrillation. Lancet (2002) 1.66
Normal pulmonary veins anatomy is associated with better AF-free survival after cryoablation as compared to atypical anatomy with common left pulmonary vein. Pacing Clin Electrophysiol (2011) 1.66
Organization of frequency spectra of atrial fibrillation: relevance to radiofrequency catheter ablation. J Cardiovasc Electrophysiol (2006) 1.65
Prognosis, disease progression, and treatment of atrial fibrillation patients during 1 year: follow-up of the Euro Heart Survey on atrial fibrillation. Eur Heart J (2008) 1.64
Localized sources maintaining atrial fibrillation organized by prior ablation. Circulation (2006) 1.63
Dissociated pulmonary vein arrhythmia: incidence and characteristics. J Cardiovasc Electrophysiol (2003) 1.63
Are women with severely symptomatic brugada syndrome different from men? J Cardiovasc Electrophysiol (2008) 1.62
Atrial fibrillation originating from persistent left superior vena cava. Circulation (2004) 1.60
Phrenic nerve injury after atrial fibrillation catheter ablation: characterization and outcome in a multicenter study. J Am Coll Cardiol (2006) 1.58
Pacemaker lead extraction with the needle's eye snare for countertraction via a femoral approach. Pacing Clin Electrophysiol (2002) 1.55
Chronic atrial fibrillation ablation impact on endocrine and mechanical cardiac functions. Eur Heart J (2007) 1.53
Mitochondrial dysfunction as an arrhythmogenic substrate: a translational proof-of-concept study in patients with metabolic syndrome in whom post-operative atrial fibrillation develops. J Am Coll Cardiol (2013) 1.53
A new dual-chamber pacing mode to minimize ventricular pacing. Pacing Clin Electrophysiol (2005) 1.52
Myocardial asynchronism is a determinant of changes in functional mitral regurgitation severity during dynamic exercise in patients with chronic heart failure due to severe left ventricular systolic dysfunction. Eur Heart J (2005) 1.52
Electrophysiologic and clinical consequences of linear catheter ablation to transect the anterior left atrium in patients with atrial fibrillation. Heart Rhythm (2004) 1.52
Long-term follow-up of persistent atrial fibrillation ablation using termination as a procedural endpoint. Eur Heart J (2009) 1.46
Outcome after implantation of a cardioverter-defibrillator in patients with Brugada syndrome: a multicenter study. Circulation (2006) 1.46
High-resolution mapping of tachycardia originating from the superior vena cava: evidence of electrical heterogeneity, slow conduction, and possible circus movement reentry. J Cardiovasc Electrophysiol (2002) 1.45
First inappropriate implantable cardioverter defibrillator therapy is often due to inaccurate device programming: analysis of the French OPERA registry. Europace (2012) 1.45
Electrophysiologically guided pulmonary vein isolation during sustained atrial fibrillation. J Cardiovasc Electrophysiol (2003) 1.45
Ventricular arrhythmias following exposure of failing hearts to oxidative stress in vitro. J Cardiovasc Electrophysiol (2005) 1.45
Paced ventricular electrogram fractionation predicts sudden cardiac death in hypertrophic cardiomyopathy. Eur Heart J (2008) 1.44
Potential cost savings by telemedicine-assisted long-term care of implantable cardioverter defibrillator recipients. Pacing Clin Electrophysiol (2005) 1.43
Mitral isthmus ablation with and without temporary spot occlusion of the coronary sinus: a randomized clinical comparison of acute outcomes. J Cardiovasc Electrophysiol (2012) 1.40
Unexpected ventricular asystole in a DDD pacemaker: what is the mechanism? Pacing Clin Electrophysiol (2002) 1.39
Tachycardia transition during ablation of persistent atrial fibrillation. J Cardiovasc Electrophysiol (2010) 1.38
Impact of a patent foramen ovale on paroxysmal atrial fibrillation ablation. J Cardiovasc Electrophysiol (2008) 1.37
Distinctive electrophysiological properties of pulmonary veins in patients with atrial fibrillation. Circulation (2002) 1.34
Reverse remodeling of sinus node function after catheter ablation of atrial fibrillation in patients with prolonged sinus pauses. Circulation (2003) 1.32
Techniques for curative treatment of atrial fibrillation. J Cardiovasc Electrophysiol (2004) 1.32
The stepwise ablation approach for chronic atrial fibrillation--evidence for a cumulative effect. J Interv Card Electrophysiol (2006) 1.30
Isthmus characteristics of reentrant ventricular tachycardia after myocardial infarction. Circulation (2002) 1.27
Reducing unnecessary right ventricular pacing with the managed ventricular pacing mode in patients with sinus node disease and AV block. Pacing Clin Electrophysiol (2006) 1.24
Contributions of remote monitoring to the follow-up of implantable cardioverter-defibrillator leads under advisory. Eur Heart J (2010) 1.21
Update of the guidelines on sudden cardiac death of the European Society of Cardiology. Eur Heart J (2003) 1.21
Automatic home monitoring of implantable cardioverter defibrillators. Europace (2008) 1.21
Optimized post-operative surveillance of permanent pacemakers by home monitoring: the OEDIPE trial. Europace (2008) 1.20
Disparate evolution of right and left atrial rate during ablation of long-lasting persistent atrial fibrillation. J Am Coll Cardiol (2010) 1.18
Personalized management of atrial fibrillation: Proceedings from the fourth Atrial Fibrillation competence NETwork/European Heart Rhythm Association consensus conference. Europace (2013) 1.16
Characterization of focal atrial tachycardia using high-density mapping. J Am Coll Cardiol (2005) 1.14
Catheter ablation for atrial fibrillation. Circulation (2007) 1.10
Sudden death in noncoronary heart disease is associated with delayed paced ventricular activation. Circulation (2003) 1.09
Complete isolation of the pulmonary veins and posterior left atrium in chronic atrial fibrillation. Long-term clinical outcome. Eur Heart J (2007) 1.08
Performance of a dual-chamber implantable defibrillator algorithm for discrimination of ventricular from supraventricular tachycardia. Europace (2004) 1.07
Inhibition of biventricular pacemakers by oversensing of far-field atrial depolarization. Pacing Clin Electrophysiol (2002) 1.07
Incidence and clinical relevance of slow ventricular tachycardia in implantable cardioverter-defibrillator recipients: an international multicenter prospective study. Circulation (2005) 1.06
Electroanatomic mapping characteristics of ventricular tachycardia in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia. Europace (2005) 1.06
Acute occlusion of the left circumflex coronary artery during mitral isthmus linear ablation. J Cardiovasc Electrophysiol (2005) 1.05
Serum BNP, hs-C-reactive protein, procollagen to assess the risk of ventricular tachycardia in ICD recipients after myocardial infarction. Europace (2007) 1.05
A deductive mapping strategy for atrial tachycardia following atrial fibrillation ablation: importance of localized reentry. J Cardiovasc Electrophysiol (2008) 1.05
High prevalence of sleep apnea syndrome in patients with long-term pacing: the European Multicenter Polysomnographic Study. Circulation (2007) 1.03
Detection of myocarditis by contrast-enhanced MRI in patients presenting with acute coronary syndrome but no coronary stenosis. J Magn Reson Imaging (2007) 1.02
How to perform linear lesions. Heart Rhythm (2007) 1.01
Effects of stepwise ablation of chronic atrial fibrillation on atrial electrical and mechanical properties. J Am Coll Cardiol (2007) 1.00
Venice Chart International Consensus document on ventricular tachycardia/ventricular fibrillation ablation. J Cardiovasc Electrophysiol (2010) 1.00